148 related articles for article (PubMed ID: 26781855)
1. Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli.
Moghaddam MM; Abolhassani F; Babavalian H; Mirnejad R; Azizi Barjini K; Amani J
Probiotics Antimicrob Proteins; 2012 Jun; 4(2):133-9. PubMed ID: 26781855
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the antibacterial effects of a short cationic peptide and 1% silver bioactive glass against extensively drug-resistant bacteria, Pseudomonas aeruginosa and Acinetobacter baumannii, isolated from burn patients.
Moosazadeh Moghaddam M; Eftekhary M; Erfanimanesh S; Hashemi A; Fallah Omrani V; Farhadihosseinabadi B; Lasjerdi Z; Mossahebi-Mohammadi M; Pal Singh Chauhan N; Seifalian AM; Gholipourmalekabadi M
Amino Acids; 2018 Nov; 50(11):1617-1628. PubMed ID: 30145712
[TBL] [Abstract][Full Text] [Related]
3. Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Del Prete MS; Łukasiak J; Scalise G
Peptides; 2003 Sep; 24(9):1315-8. PubMed ID: 14706545
[TBL] [Abstract][Full Text] [Related]
4. In vitro synergistic effect of the CM11 antimicrobial peptide in combination with common antibiotics against clinical isolates of six species of multidrug-resistant pathogenic bacteria.
Amani J; Barjini KA; Moghaddam MM; Asadi A
Protein Pept Lett; 2015; 22(10):940-51. PubMed ID: 26216264
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cells.
Moghaddam MM; Barjini KA; Ramandi MF; Amani J
World J Microbiol Biotechnol; 2014 May; 30(5):1533-40. PubMed ID: 24323118
[TBL] [Abstract][Full Text] [Related]
6. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
[TBL] [Abstract][Full Text] [Related]
7. Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.
Saugar JM; Rodríguez-Hernández MJ; de la Torre BG; Pachón-Ibañez ME; Fernández-Reyes M; Andreu D; Pachón J; Rivas L
Antimicrob Agents Chemother; 2006 Apr; 50(4):1251-6. PubMed ID: 16569836
[TBL] [Abstract][Full Text] [Related]
8. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
Dosler S; Karaaslan E
Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
[TBL] [Abstract][Full Text] [Related]
9. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W
Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide, against multiresistant Acinetobacter baumannii strains.
Alarcón T; López-Hernández S; Andreu D; Saugar JM; Rivas L; López-Brea M
Rev Esp Quimioter; 2001 Jun; 14(2):184-90. PubMed ID: 11704773
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
13. Activities of synthetic peptides against human pathogenic bacteria.
Bogucka K; Królicka A; Kamysz W; Ossowski T; Lukasiak J; Lojkowska E
Pol J Microbiol; 2004; 53(1):41-4. PubMed ID: 15330266
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
[TBL] [Abstract][Full Text] [Related]
15. A Novel Cecropin D-Derived Short Cationic Antimicrobial Peptide Exhibits Antibacterial Activity Against Wild-Type and Multidrug-Resistant Strains of
Ocampo-Ibáñez ID; Liscano Y; Rivera-Sánchez SP; Oñate-Garzón J; Lugo-Guevara AD; Flórez-Elvira LJ; Lesmes MC
Evol Bioinform Online; 2020; 16():1176934320936266. PubMed ID: 32636607
[TBL] [Abstract][Full Text] [Related]
16. Osmoprotection of bacterial cells from toxicity caused by antimicrobial hybrid peptide CM15.
Sato H; Feix JB
Biochemistry; 2006 Aug; 45(33):9997-10007. PubMed ID: 16906758
[TBL] [Abstract][Full Text] [Related]
17. Determination of antibacterial activity and minimum inhibitory concentration of larval extract of fly via resazurin-based turbidometric assay.
Teh CH; Nazni WA; Nurulhusna AH; Norazah A; Lee HL
BMC Microbiol; 2017 Feb; 17(1):36. PubMed ID: 28209130
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens.
Al-Ani I; Zimmermann S; Reichling J; Wink M
Phytomedicine; 2015 Feb; 22(2):245-55. PubMed ID: 25765829
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of an antimicrobial peptide against amastigote forms of
Khalili S; Mohebali M; Ebrahimzadeh E; Shayan E; Mohammadi-Yeganeh S; Moosazadeh Moghaddam M; Elikaee S; Akhoundi B; Sharifi-Yazdi MK
Vet Res Forum; 2018; 9(4):323-328. PubMed ID: 30713610
[TBL] [Abstract][Full Text] [Related]
20. Anti-amoebic activity of a cecropin-melittin hybrid peptide (CM11) against trophozoites of Entamoeba histolytica.
Mahdavi Abhari F; Pirestani M; Dalimi A
Wien Klin Wochenschr; 2019 Sep; 131(17-18):427-434. PubMed ID: 31451929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
